InMed Pharmaceuticals Inc. Common Shares

INMNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.44 USD
↗ 0.11 (8.27%)AT CLOSE (03:59 PM EDT)
1.40
↘ 0.04 (2.78%)
POST MARKET (AS OF 07:19 PM EDT)
Post Market
AS OF 07:19 PM EDT
1.40
↘ 0.04 (2.78%)
🔴Market: CLOSED

InMed Pharmaceuticals Inc. Common Shares (INM) is currently trading at $1.44. INM shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place INM at a fair price relative to peers.

Technical & fundamental data as of Oct 23, 2026.

Open?$1.32
High?$1.54
Low?$1.32
Prev. Close?$1.33
Volume?125.9K
Avg. Volume?54.7K
VWAP?$1.42
Rel. Volume?2.30x
Bid / Ask
Bid?$1.36 × 700
Ask?$1.47 × 1.0K
Spread?$0.11
Midpoint?$1.42
Valuation & Ratios
Market Cap?7.9M
Shares Out?5.5M
Float?3.3M
Float %?99.2%
P/E Ratio?N/A
P/B Ratio?7.36
EPS?-$2.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsCannabis›CBD & Hemp Products
Employees
6
Market Cap
7.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.inmedpharma.com
Listed
2020-11-10
Address
C/O NORTON ROSE FULBRIGHT CANADA LLP
VANCOUVER, V6B 0M3
Phone: (604) 669-7207
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-67.57Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.04%Low
Short Interest?34.1K
Days to Cover?1.0
Free Float3.3M
Avg Daily Volume78.9K
Settlement Date2026-09-30
Financial Health
Current Ratio?1.45Adequate
Quick Ratio?1.45Adequate
Cash Ratio?1.19Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
25
7.36FAIR▾
P/S?
Peers
100
S&P
37
4.08FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.6CHEAP▾
EV/Sales?
Peers
100
S&P
61
2.95CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-1,208.6%WEAK▾
ROA?
S&P
3
-428.8%WEAK▾
Cash Flow & Enterprise
FCF?$-8643513
Enterprise Value?$5.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist